PT - JOURNAL ARTICLE AU - Lee, Yung-Chun AU - Liu, Lufeiya AU - Yuan, Liyang AU - Risk, Malcolm AU - Heinrich, Kevin AU - Witteveen-Lane, Martin AU - Hayek, Salim AU - Malosh, Ryan AU - Pop-Busui, Rodica AU - Jiang, Bian AU - Shen, Chen AU - Chesla, Dave AU - Kennedy, Richard AU - Xu, Shi AU - Sims, Matthew AU - Homayouni, Ramin AU - Zhao, Lili TI - Influenza vaccine effectiveness against hospitalized SARS-CoV-2 infection AID - 10.1101/2023.10.27.23297682 DP - 2023 Jan 01 TA - medRxiv PG - 2023.10.27.23297682 4099 - http://medrxiv.org/content/early/2023/10/31/2023.10.27.23297682.short 4100 - http://medrxiv.org/content/early/2023/10/31/2023.10.27.23297682.full AB - Background Some studies conducted before the Delta and Omicron variant-dominant periods have indicated that influenza vaccination provided protection against COVID-19 infection or hospitalization, but these results were limited by small study cohorts and a lack of comprehensive data on patient characteristics. No studies have examined this question during the Delta and Omicron periods (08/01/2021 to 2/22/2022).Methods We conducted a retrospective cohort study of influenza-vaccinated and unvaccinated patients in the Corewell Health East(CHE, formerly known as Beaumont Health), Corewell Health West(CHW, formerly known as Spectrum Health) and Michigan Medicine (MM) healthcare system during the Delta-dominant and Omicron-dominant periods. We used a test-negative, case-control analysis to assess the effectiveness of the influenza vaccine against hospitalized SARS-CoV-2 outcome in adults, while controlling for individual characteristics as well as pandameic severity and waning immunity of COVID-19 vaccine.Results The influenza vaccination has shown to provided some protection against SARS-CoV-2 hospitalized outcome across three main healthcare systems. CHE site (odds ratio [OR]=0.73, vaccine effectiveness [VE]=27%, 95% confidence interval [CI]: [18-35], p<0.001), CHW site (OR=0.85, VE=15%, 95% CI: [6-24], p<0.001), MM (OR=0.50, VE=50%, 95% CI: [40-58], p <0.001) and overall (OR=0.75, VE=25%, 95% CI: [20-30], p <0.001).Conclusion The influenza vaccine provides a small degree of protection against SARS-CoV-2 infection across our study sites.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health R01AI158543.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study sites included in this study, Michigan Medicine, Corewell health East, Corewell Health West 's Institutional Review Board all granted approval for this work and supplies de-identified EHR for subjects for the study cohort.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesDue to the sensitivity of real-world data, de-identified patient level are not available for public, only results, figures and tables are contained in the manuscript.